Search
Nurix Therapeutics Inc
NRIXAdd to Watchlist
18.675USD
+1.125+6.41%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
1.93BMarket Cap
LossP/E TTM
Nurix Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-22The current valuation score of Nurix Therapeutics Inc is 6.92, ranking 281 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.89, which is -73.62% below the recent high of -1.55 and -64.97% above the recent low of -9.71.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
